Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: PDSG sale
11
Jul 17, 2010 03:55PM

The 120 day time frame was clearly stated in open forum at the Annual Meeting, therefore predating Felcyn's confirmation in the email.

A)Stay the course (i.e. go it alone) – Multi Year Commitment (to get foot in the door and gain traction in sales) – focus on Justice and Public Safety – State and Local governments. Problem is these entities are risk averse and rather deal with big companies they already know and have dealt with. With this alternative, PTSC would have to target more market sectors. At the end of February, there will be a new version of CDX.
B)2nd Alternative. Staying on course is not best permanent course for PTSC. Alternative #2 is Partnering, being led by BIG partner who has that name recognition. Eclat is looking for the Partner and can achieve access to key people in these potential partners (i.e. the person(s)that can make the decisions to partner up with PTSC). PTSC will share info with shareholders when they know who that partner will be.
Other stiff Cliff said:
-M & A on hold
Alternatives to do: Rebuild cash, start up dividends, renew purchase of shares – all things they are evaluating (Bottom line I interpreted, is they (and we obviously) have been burned and are proceeding very cautiously). The plan is to develop alternatives in conjunction with a permanent CEO. Obtaining a CEO maybe be 90-120 days out. I didn't sense that this was imminent

http://forum.finanzen.net/forum/killercop-t261359?page=143

.

.

.

Be well

6
Jul 17, 2010 08:54PM
Share
New Message
Please login to post a reply